CClinicalTrials.gg
RecruitingNCT06115083Updated Apr 16, 2024

Effects of Pelvic Floor Training in Male Chronic Pelvic Pain, Correlation Between Subjective and Objective Outcomes

An interventional study of Pelvic floor re-education using bio-feedback and home training in Chronic Pelvic Pain Syndrome, Chronic Prostatitis With Chronic Pelvic Pain Syndrome and Chronic Prostatitis, sponsored by Region Stockholm. Recruiting at 1 site in Sweden. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-16.

Sponsored by Region Stockholm · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

The goal of this randomized controlled study is to establish the long-term effect of pelvic floor re-education using biofeedback and home training for men with chronic pelvic pain. The main questions it aims to answer are if pelvic floor re-education using bio-feedback and home training will give a long-lasting improvement in symptoms, assessed with a validated symptom score (the National Institute of Health - Chronic Prostatitis Symptom Index) and if an improvement in symptoms can be correlated to objective measurements of pelvic floor function. Participants will be asked to do pelvic floor exercises daily during six months with additional sessions of bio-feedback training. The control group will have no changes in their on-going treatment for their chronic pelvic pain and will be offered to enter the treatment group after six months.

Read the detailed description

At baseline all included study subjects will fill in a validated symptom score, the National Institute of Health - Chronic Prostatitis Symptom Index (NIH-CPSI) and have an assessment of their pelvic floor muscles and undergo a urodynamic evaluation.

The intervention group will perform short daily session of pelvic floor muscle training at home during six months in combination with four bio-feedback sessions during the first months. The study subjects will receive an individual instruction based on the pelvic floor assessment from the baseline visit. The study subjects will report their training in a digital diary.

A reevaluation will be done at three, six and twelve months. At six and 12 months repeating the baseline tests. At three months a renewed assessment of muscle function and the NIH-CPSI questionnaire.

The control group will be instructed not to engage in any new treatment for their chronic pelvic pain during the study period. After the six months evaluation all participants in the control group will be offered to be enrolled in the treatment group, with the same set-up and follow-up as the treatment group.

02

Conditions studied

  • Chronic Pelvic Pain Syndrome
  • Chronic Prostatitis With Chronic Pelvic Pain Syndrome
  • Chronic Prostatitis
  • Pelvic Floor; Relaxation

Keywords

  • Chronic pelvic pain syndrome
  • Chronic prostatitis with chronic pelvic pain syndrome
  • Chronic prostatitis
  • Pelvic floor muscles
  • Urodynamics
  • Physiotherapy
  • Bio-feedback
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Men over the age of 18, residents in Sweden, diagnosed with Chronic Primary Pelvic Pain Syndrome (CPPPS) according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (N41.1 (chronic prostatitis), N41.9 (Inflammatory disease of prostate, unspecified), N50.8F (Chronic Pelvic Pain Syndrome in men)

Exclusion criteria

Exclusion Criteria:

  • Cancer in the abdomen or pelvic organs (current or previous)
  • Congenital anomalies affecting the pelvic region (Bladder exstrophy, Myelomeningocele etc.)
  • Transsexual male, (i.e. at birth biologically female)
  • Diseases affecting the nerve function to the pelvic and/or lower extremities, other disease or ongoing treatment that could have an impact on the outcome of the study.
  • Incapability to participate in testing or follow training instructions due to mental incapacity, language difficulties etc.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Pelvic floor muscle re-education

    Intervention with pelvic floor re-education using bio-feedback and home training for 6 months, with a follow up visit after an additional period of 6 months

    Other: Pelvic floor re-education using bio-feedback and home training

  • No intervention
    Standard Care

    No intervention during 6 months after inclusion. After the 6 month follow-up evaluation the study subjects are offered to participate in the interventional arm.

Interventions

  • OtherPelvic floor re-education using bio-feedback and home training

    Pelvic floor re-education using bio-feedback and home training

05

What researchers measure

Primary outcomes

  1. Change in symptom score on the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire

    Change in total score, range from 0-43 points. Higher score indicates worse symptoms.

    Time frame: Measured 3, 6 and 12 months after inclusion

Secondary outcomes

  1. Change in sub score on the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire

    Sub score according to the domains; pain 0-21, urological symptoms 0-10 points and quality of life impact 0-12 points. Higher score indicates worse symptoms in all three domains.

    Time frame: Measured 3, 6 and 12 months after inclusion

  2. Changes in global voiding function using free flow non-invasive urodynamic testing

    Changes in global voiding function using free flow non-invasive urodynamic testing with electromyogram. Global assessment where combined results from maximum urinary flow rate, voided volume, post voiding residual volume, pelvic floor activity during voiding and the shape of the curve are used to define types of voiding patterns. * Normal flow * Asymmetrical obstructive flow * Symmetrical low flow * Irregular curve, straining flow * Plateau low flow As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams.

    Time frame: Measured 6 and 12 months after inclusion

  3. Changes in global storing function of the bladder using invasive urodynamics, cystometry

    Changes in global bladder function using invasive urodynamics with cystometry with electromyogram. Global assessment where combined results from sensory input, cystometric capacity, detrusor activity, compliance and pelvic floor activity are combined to define different patterns. * Normal cystometry * Abnormal sensory input * Detrusor activity * Abnormal compliance * Abnormal bladder capacity As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams.

    Time frame: Measured 6 and 12 months after inclusion

  4. Changes in global voiding function using invasive urodynamics, pressure-flow study

    Changes in global voiding function using invasive urodynamics, pressure-flow study with electromyogram. Global assessment where combined results from detrusor contractility, urinary flow and pelvic floor activity are combined to define different patterns. * Normal flow * Under-active flow * Obstructed flow As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams.

    Time frame: Measured 6 and 12 months after inclusion

  5. Changes in urethral pressure using invasive urodynamics, urethral pressure profile

    Changes in urethral pressure using invasive urodynamics, urethral pressure profile. * Maximum urethral pressure (cmH2O) * Maximum urethral closure pressure (cmH2O) As described in Urodynamics (third edition) by P. Abrams.

    Time frame: Measured 6 and 12 months after inclusion

  6. Changes in pelvic floor muscle assessment according to test specifics by Frawley et al 2021 and the modified Oxford Scale according to Laycock et al 2001.

    Pelvic floor muscle assessment according to test specifics by Frawley et al 2021 1. Assessment of muscle tone - Decreased / normal / increased 2. Assessment of voluntary contraction - No contraction / correct contraction / contraction only with help from other muscles / uncertain / straining 3. Assessment of relaxation post contraction - Yes / partial or delayed / no 4. Assessment of tenderness * Yes / No * If yes location is noted and severity of pain is graded according to numeric rating scale, 0-10, with higher value indicatinge more severe pain. Modified Oxford Scale for assessment of pelvic floor muscle power, graded from 0-5 with higer value indicating stronger power.

    Time frame: Measured 3, 6 and 12 months after inclusion

  7. Correlation between subjective and objective measurements

    Correlation between subjective measurements using the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire and objective findings on urodynamic testing and pelvic floor assessment.

    Time frame: Measured 3, 6 and 12 months after inclusion

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06115083
Lead sponsor
Region Stockholm
Collaborators
Karolinska Institutet
Responsible party
Lotta Renström Koskela (Principal Investigator, Region Stockholm) — Principal investigator
First posted
Nov 2, 2023
Start date
Dec 1, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 16, 2024

Study contacts

Lotta Renström Koskela, M.D
Contact
lotta.renstrom-koskela@regionstockholm.se
+46-8-12370000
Lotta Renström Koskela, M.D
principal investigator · Karolinska University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion